Synthesis and binding characteristics of N-(1-naphthyl)-N′-(3-[125I]-iodophenyl)-N′-methylguanidine ([125I]-CNS 1261): a potential SPECT agent for imaging NMDA receptor activation
Authors:
- Jonathan OwensJOJonathan Owens
- Andrew A TebbuttATAndrew A Tebbutt
- Ailsa L McGregorAMAilsa L McGregor
- K KodamaKKK Kodama
- Sharad S MagarSMSharad S Magar
- Michael E PerlmanMPMichael E Perlman
- David J RobinsDRDavid J Robins
- Graham J DurantGDGraham J Durant
- James McCullochJMJames McCulloch
- 1 June 2000
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 27 (6) , 557-564
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Treatment of Acute Ischemic Stroke With PiracetamStroke, 1997
- Lubeluzole Treatment of Acute Ischemic StrokeStroke, 1997
- Synthesis of Radiopharmaceuticals via Organotin IntermediatesSynthesis, 1996
- Safety and Tolerability of the Glutamate Antagonist CGS 19755 (Selfotel) in Patients With Acute Ischemic StrokeStroke, 1995
- The neuroprotective action of dizocilpine (MK‐801) in the rat middle cerebral artery occlusion model of focal ischaemiaBritish Journal of Pharmacology, 1991
- Excitatory amino acid receptors, neural membrane phospholipid metabolism and neurological disordersBrain Research Reviews, 1991
- Glutamate neurotoxicity and diseases of the nervous systemNeuron, 1988
- Quantitative autoradiography of [3H]‐MK‐801 binding sites in mammalian brainBritish Journal of Pharmacology, 1988
- The Role of Glutamate in Neurotransmission and in Neurologic DiseaseArchives of Neurology, 1986
- Glutamate: A Neurotransmitter in Mammalian BrainJournal of Neurochemistry, 1984